Table 2.
Case | CD30 staining in LP cells | CD45 | CD20 | PAX5 | BCL6 | BOB1/OCT2 | EBER |
---|---|---|---|---|---|---|---|
1 | +, rare | + | + | ND | ND | ND | ND |
2 | ++, rare | ND | + | ND | ND | ND | − |
3 | ++, rare | ND | + | ND | ND | ND | ND |
4 | ++, rare | + | + | ND | ND | ND | ND |
5 | ++, rare | ND | + | ND | ND | ND | − |
6 | +, rare | ND | + | + | + | ND | − |
7 | +, rare | + | + | ND | ND | ND | ND |
8 | +, rare | ND | + | ND | + | ND | ND |
9 | +, rare | ND | + | + | + | +/+ | ND |
10 | ++, many | + | + | ND | + | +/+ | − |
11 | +, rare | + | + | ND | ND | ND | ND |
12 | ++, many | ND | + | + | + | +/+ | − |
13 | +, rare | ND | + | ND | ND | ND | ND |
14 | +, rare | + | + | ND | ND | ND | − |
15 | +, rare | Faint + | + | ND | ND | +/+ | − |
16 | +, rare | ND | + | ND | ND | +/+ | ND |
17 | +, rare | ND | + | ND | ND | ND | ND |
18 | +, rare | ND | + | ND | ND | ND | ND |
19 | +, rare | ND | + | + | + | +/+ | − |
20 | ++,many | + | + | + | + | +/+ | − |
21 | +, rare | ND | + | + | + | +/+ | ND |
+ faint staining of LP cells, ++ strong staining of LP cells
ND not done